WallStreetZenWallStreetZen

NASDAQ: ATOS
Atossa Therapeutics Inc Stock Ownership - Who owns Atossa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atossa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steven C. QuayPresident CEO2025-05-2111,239$0.88
$9.89kBuy
H. Lawrence RemmelDirector2025-03-2610,000$0.70
$7.00kBuy

1 of 1

ATOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATOS insiders and whales buy or sell their stock.

ATOS Shareholders

What type of owners hold Atossa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shuchih Chen105.62%9,095,173$49.93MInsider
Vanguard Group Inc71.39%6,147,838$33.75MInstitution
Steven C. Quay60.32%5,194,684$28.52MInsider
Ameriprise Financial Inc44.02%3,791,061$20.81MInstitution
Renaissance Technologies LLC23.95%2,062,838$11.32MInstitution
Blackrock Inc23.20%1,997,627$10.97MInstitution
Geode Capital Management LLC15.93%1,371,909$7.53MInstitution
Millennium Management LLC14.43%1,242,868$6.82MInstitution
Jacobs Levy Equity Management Inc12.17%1,048,289$5.76MInstitution
Citadel Advisors LLC7.53%648,115$3.56MInstitution

1 of 3

ATOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATOS60.10%39.90%Net Buying
TELO6.65%24.95%
INKT0.63%99.37%Net BuyingNet Buying
ALGS6.85%93.15%
LITS22.74%50.97%Net Selling
View Top Biotech Stocks

Atossa Therapeutics Stock Ownership FAQ

Who owns Atossa Therapeutics?

Atossa Therapeutics (NASDAQ: ATOS) is owned by 255.24% institutional shareholders, 169.42% Atossa Therapeutics insiders, and 0.00% retail investors. Shuchih Chen is the largest individual Atossa Therapeutics shareholder, owning 9.10M shares representing 105.62% of the company. Shuchih Chen's Atossa Therapeutics shares are currently valued at $46.48M.

If you're new to stock investing, here's how to buy Atossa Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.